... thyroid tumors, prostate tumor and breast tumor. [22, 23] 3.17 Hydroxy Indole Acetic Acid: It is tumor marker of first choice ... Unlike other biological markers, for example plasmatic catecholamines, the rates of CGA are affected by neither stress nor the ... Different tumor markers are found in different types of cancer, and levels of the same tumor marker can be altered in more than ... Like any elevated tumor marker, elevated AFP by itself is not diagnostic, only suggestive. Tumor markers are used primarily to ...http://spotidoc.com/doc/23503/review
U.S. Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology...
Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, ... detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further ... U.S., Total Tumor Marker Sales Forecast by Market Segment U.S., All Market Segment Major Tumor Marker Sales Forecast by Test U. ... U.S., Total Tumor Marker Test Volume Forecast by Market Segment U.S., All Market Segments Major Tumor Marker Test Volume ...http://www.reportsnreports.com/reports/714981-us-tumor-markers-supplier-shares-by-test-competitive-strategies-country-volume-and-sales-segment-forecasts-technology-trends-instrumentation-review-emerging-opportunities.html
2015 CA Tumor Marker Testing Technologies and Emerging Markets
... Published by VPGMarketResearch.com at researchbeam.com [Report ... detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further ... 2015 CA Tumor Marker Testing Technologies and Emerging Markets Research Beam Model: Research Beam Product ID: 221461 3500 USD ... as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, ...https://www.researchbeam.com/2015-ca-tumor-marker-testing-technologies-and-emerging-market
Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer | Clinical Cancer Research
Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer. Lilian U. Thompson, Jian Min Chen, Tong Li, ... Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer. Lilian U. Thompson, Jian Min Chen, Tong Li, ... Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer. Lilian U. Thompson, Jian Min Chen, Tong Li, ... Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer Message Subject (Your Name) has forwarded a ...http://clincancerres.aacrjournals.org/content/11/10/3828
Utility of OCT3/4, TSPY and β-Catenin as Biological Markers for Gonadoblastoma Formation and Malignant Germ Cell Tumor...
... and clinical studies related to the identification of disease markers, the elucidation of their role and mechanism, as well as ... Disease Markers is a peer-reviewed, Open Access journal that publishes original research articles, review articles, ... Utility of OCT3/4, TSPY and β-Catenin as Biological Markers for Gonadoblastoma Formation and Malignant Germ Cell Tumor ... CONCLUSIONS: The use of this biological markers detects the potential high risk gonads. ...https://www.hindawi.com/journals/dm/2013/951751/abs/
Comparative cytokeratin expressio... preview & related info | Mendeley
Mucoepidermoid carcinoma is the most common malignant salivary gland tumor, composed of several different cell types, with ... Tumor Markers, Biological. *Young Adult. *classification. *metabolism. *pathology. Get free article suggestions today. Mendeley ... Mucoepidermoid carcinoma is the most common malignant salivary gland tumor, composed of several different cell types, with ... in order to establish a possible correlation between tumor cells immunostaining and mucoepidermoid carcinoma histogenesis and ...https://www.mendeley.com/research-papers/comparative-cytokeratin-expression-different-cell-types-salivary-gland-mucoepidermoid-carcinoma/
Center for Theoretical & Mathematical Sciences » People
Tumor Markers, Biological • Tyrosine • Tyrosine 3-Monooxygenase • United States • Up-Regulation • Vacuoles • Vitamin B 12 ... Biological Evolution • Biological Markers • Biological Transport • Biomass • Biometry • Body Constitution • Body Patterning • ... Nijhout, HF; Reed, MC; Ulrich, CM, A day in the life of cell metabolism., Biological Theory (in press) (2007) *H.F. Nijhout, ... Nijhout, HF; Suzuki, Y, Environment and genetic accommodation., Biological Theory, vol. 3 no. 1-9 (2009) *Suzuki Y, Nijhout HF ...http://fds.duke.edu/db/aas/math/ctms/faculty/hfn
Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancer.
... we evaluated the prognostic value of the tumour marker, tissue polypeptide-specific antigen (TPS), in 203 patients with non- ... 0/Peptides; 0/Tissue Polypeptide Antigen; 0/Tumor Markers, Biological; EC 184.108.40.206/L-Lactate Dehydrogenase; EC 220.127.116.11/gamma- ... In this study, we evaluated the prognostic value of the tumour marker, tissue polypeptide-specific antigen (TPS), in 203 ... Previous Document: Adult Wilms' tumour: review of 22 cases.. Next Document: In vivo cell kinetic measurements in human ...http://www.biomedsearch.com/nih/Prognostic-significance-tissue-polypeptide-specific/7880606.html
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.
... is a highly aggressive brain tumour, where patients respond poorly to radiotherapy and exhibit dismal survival outcomes. The ... 0/Antigens; 0/Proteoglycans; 0/Tumor Markers, Biological; 0/chondroitin sulfate proteoglycan 4 ... B brain, S guide-screw, T tumour, n number of animals (adapted from ). b Tumour sizes in vivo before IR treatment (top ... 6a). The 125I seeds delivered a dose of 1.8 Gy Bio Equivalent Dosetumour (BEDtumour) for 12 days at 2.5 mm below the seed, 2.7 ...http://www.biomedsearch.com/nih/Expression-progenitor-marker-predicts-poor/21863242.html
Personalized oncology in interventional radiology.
0/Antineoplastic Agents; 0/Tumor Markers, Biological Comments/Corrections. From MEDLINE®/PubMed®, a database of the U.S. ... Several mutations and key markers already have been introduced into standard oncologic practice. A broader understanding of ... and tumor angiogenesis. A new era of personalized medicine has evolved whereby clinical decisions are adjusted according to a ...http://www.biomedsearch.com/nih/Personalized-oncology-in-interventional-radiology/23885909.html
Intramedullary endometriosis of the conus medullaris: case report.
Tumor Markers, Biological / analysis, metabolism. Urinary Bladder, Neurogenic / diagnosis, etiology, physiopathology. Chemical ...http://www.biomedsearch.com/nih/Intramedullary-endometriosis-conus-medullaris-case/16883155.html
Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas.
0/KRAS protein, human; 0/Proto-Oncogene Proteins; 0/Tumor Markers, Biological; EC 18.104.22.168/EGFR protein, human; EC 22.214.171.124/ ...http://www.biomedsearch.com/nih/Combined-Use-ALK-Immunohistochemistry-FISH/23407557.html
Medical devices; reclassification of tumor-associated antigen immunological test system--FDA. Final rule.
... is announcing that it is codifying the reclassification of tumor-associated antigen immunological test systems intended as an ... Tumor Markers, Biological / classification*, standards. United States. United States Food and Drug Administration. ... reclassifying serum tumor markers into class II. This action is being taken under the Federal Food, Drug, and Cosmetic Act (the ... The Food and Drug Administration (FDA) is announcing that it is codifying the reclassification of tumor-associated antigen ...http://www.biomedsearch.com/nih/Medical-reclassification-tumor-associated-antigen/10179301.html
FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.
Tumor Markers, Biological / genetics. Tumor Suppressor Protein p53 / genetics, metabolism. Urinary Bladder Neoplasms / ... 0/Tumor Markers, Biological; 0/Tumor Suppressor Protein p53; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 126.96.36.199/PIK3CA ... Additionally, in primary tumors p53 expression was obtained by immunohistochemistry. Of primary tumors 64% were mutant for ... In patients presenting with NMI-BC grade 3 and MI-BC, 33 and 36% of the primary tumors were mutant. In patients with low-grade ...http://www.biomedsearch.com/nih/Fgfr3-hras-kras-nras-pik3ca/21072204.html
Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.
Tumor Markers, Biological / metabolism. Urinary Bladder Neoplasms / metabolism, pathology*, surgery. Chemical. Reg. No./ ... The tumor cells are negative for E-cadherin, but positive for CD138 expression. This particular patient died 3 months after the ... CONCLUSIONS: PUC is a rare tumor associated with poor prognosis due to its advanced clinical stage upon its diagnosis. The ... The patient underwent radical cystectomy, and the representative sections of tumor were submitted for immunohistochemical ...http://www.biomedsearch.com/nih/Plasmacytoid-urothelial-carcinoma-urinary-bladder/22949945.html
Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
0/Antigens, CD30; 0/Immunosuppressive Agents; 0/Keratolytic Agents; 0/Tumor Markers, Biological; 54350-48-0/Etretinate; 59865- ... 19294485 - T cell lymphoblastic lymphoma in parotidectomy for warthin's tumor: case report and rev.... 8169515 - Bilateral ...http://www.biomedsearch.com/nih/Primary-cutaneous-CD30-large-T/12771475.html
Benign mesenchymal tumours and tumour-like lesions in end-stage renal disease.
0/Tumor Markers, Biological ... Benign mesenchymal tumours and tumour-like lesions in end-stage ... Tumour-like smooth muscle proliferations were seen surrounding muscular arteries (eight), occasionally admixed with fat ...http://www.biomedsearch.com/nih/Benign-mesenchymal-tumours-tumour-like/23020314.html
Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.
0/Autoantibodies; 0/Tumor Markers, Biological; 0/Tumor Suppressor Protein p53 From MEDLINE®/PubMed®, a database of the U.S. ...http://www.biomedsearch.com/nih/Serum-p53-autoantibodies-as-prognostic/11911308.html
Circulating neuroendocrine markers in patients with prostate carcinoma.
Circulating neuroendocrine markers were measured in patients with prostate carcinoma (PC), prostatic intraepithelial neoplasia ... 0/Chromogranin A; 0/Chromogranins; 0/Tumor Markers, Biological; EC 188.8.131.52/Phosphopyruvate Hydratase ... Next Document: MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance.... ... BACKGROUND: Circulating neuroendocrine markers were measured in patients with prostate carcinoma (PC), prostatic ...http://www.biomedsearch.com/nih/Circulating-neuroendocrine-markers-in-patients/10861438.html
Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
0/Antigens, CD; 0/Antineoplastic Agents, Alkylating; 0/Isoenzymes; 0/Tumor Markers, Biological; 305-03-3/Chlorambucil; EC 3.1.3 ... Previous Document: D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tum.... ...http://www.biomedsearch.com/nih/Hairy-cell-leukemia-variant-in/21326814.html
CEA levels in serum and BAL in patients suffering from lung cancer | SpringerLink
CEA is synthesized by epithelial and tumor cells. In this study, CEA... ... is a tumor marker belonging to the immunoglobulin gene superfamily of adhesion molecules. ... Clinical and biological relevance of lung tumor markers.Diagn Oncol 1991;1: 305-315.Google Scholar ... Niklinski J, Furman M. Clinical tumor markers in lung cancer.Eur J Cancer Prev 1995;4: 129-138.PubMedCrossRefGoogle Scholar ...https://link.springer.com/article/10.1007%2FBF02698043
Ultra-fast processing of gigapixel Tissue MicroArray images using high performance computing. - NextBio article
Tumor Markers, Biological Substances Tumor Markers, Biological PMID: 21127378. View Full Text ...http://www.nextbio.com/b/search/article.nb?id=21127378
Retinal Dehydrogenase Summary Report | CureHunter
Biological Tumor Markers (Tumor Markers) 10. Thioredoxins CureHunter Inc. provides medical information and specifically does ... "The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or ...http://www.curehunter.com/public/keywordSummaryD050697-Retinal-Dehydrogenase.do
Chorionic Gonadotropin - Human Chorionic Gonadotropin Summary Report | CureHunter
... but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). ... Biological Markers (Surrogate Marker) 4. Gonadotropins 5. Biological Tumor Markers (Tumor Markers) ... Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 03/13/1992 - "It has an important role in germ cell tumors and in ... 07/01/2005 - "In this study, MA-10 mouse Leydig tumor cells were treated with vehicle, different dosages of TM with or without ...http://www.curehunter.com/public/keywordSummaryD006063-Chorionic-Gonadotropin-Human-Chorionic-Gonadotropin.do
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. - CAPRARO Valérie
Tumor Markers, Biological/metabolism. Abstract :. [en] OBJECTIVE: Telomeres are protected by tightly regulated factors and ...http://orbi.ulg.ac.be/handle/2268/110202